About Ground Fluor Pharmaceuticals
Ground Fluor Pharmaceuticals is a company based in Lincoln (United States) founded in 2012. Ground Fluor Pharmaceuticals operates in a competitive market with competitors including ARTMS, NorthStar Medical Radioisotopes, Niowave, AZI and Nanovista, among others.
- Headquarter Lincoln, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
America’s Seed Fund
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Ground Fluor Pharmaceuticals
Investors in Ground Fluor Pharmaceuticals
Ground Fluor Pharmaceuticals has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include America’s Seed Fund and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed by the US Government
|
Locked | Locked | Locked | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked |
Investor details for Ground Fluor Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ground Fluor Pharmaceuticals
Investment portfolio details for Ground Fluor Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ground Fluor Pharmaceuticals
Detailed financials for Ground Fluor Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ground Fluor Pharmaceuticals Comparisons
Peer comparison for Ground Fluor Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ground Fluor Pharmaceuticals
Ground Fluor Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ARTMS, NorthStar Medical Radioisotopes, Niowave, AZI and Nanovista, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Radioisotope technologies and services are developed and provided by ARTMS.
|
|
| Locked | Locked | Locked |
Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market
|
|
| Locked | Locked | Locked |
Devices and radioisotopes for nuclear imaging are provided by Niowave.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for diagnostic imaging are developed and produced.
|
|
| Locked | Locked | Locked |
Multimodal visualization agents are developed for image-guided interventions.
|
Detailed competitors of Ground Fluor Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ground Fluor Pharmaceuticals
Complete news archive for Ground Fluor Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ground Fluor Pharmaceuticals
Ground Fluor Pharmaceuticals was founded in 2012.
Ground Fluor Pharmaceuticals is headquartered in Lincoln, United States. It is registered at Lincoln, Nebraska, United States.
Ground Fluor Pharmaceuticals was founded in 2012 in Lincoln, United States, within the biomedical sector. Proprietary chemistry is developed for synthesizing pharmaceutical compounds, particularly Fluorine F-18 agents used in positron emission tomography imaging. The SWIFT platform technology, known as Swift Iodonium Fluorine Tagging, enables production of F18 radiopharmaceuticals with higher yields, potency, and reliability compared to existing methods. Pipeline products encompass 18F-m-Fluorobenzylguanidine, 18F-FPEB, 6-18F-Fluoro-L-DOPA, and 6-18F-Fluorophenylalanine.
Ground Fluor Pharmaceuticals's top competitors include ARTMS, NorthStar Medical Radioisotopes and Niowave.
Ground Fluor Pharmaceuticals has 2 investors. Key investors include America’s Seed Fund, and National Science Foundation.